Teva Facing Infringement Suit Over Generic Pain Med ANDA
BioDelivery Sciences International Inc. has accused Teva Pharmaceuticals Inc. of infringing its patents for opioid pain management medication Belbuca with a generic version, according to a Delaware federal court lawsuit filed...To view the full article, register now.
Already a subscriber? Click here to view full article